Brief: Innovent Biologics Inc Announces Strategic Collaboration With Ascentage Pharma Group International
14/07/2021 15:06
July 14 (Reuters) - Innovent Biologics Inc 1801.HK :
* ANNOUNCES STRATEGIC COLLABORATION WITH ASCENTAGE PHARMA
GROUP
INTERNATIONAL
* COLLABORATION ON HQP1351 AND APG-2575
Further company coverage: 1801.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up